Read about the latest industry insights
No one should accept “good enough” for pharmaceutical cold-chain
Cihan Likogullari, head of EMEA at Envirotainer, explains the four pillars of success on which active cold-chain rest and why taking a “good enough” approach is not acceptable.
Taking control of cold-chain risk
Brian Cooper, Head of Sales Americas at Envirotainer, knows plenty can go wrong when transporting medicines. He shares his ideas for reducing risk.
How pharma can save money and be friendlier to the planet
In the pharma industry, approximately 90% of all carbon emissions are generated in the manufacturing phase. The biggest positive impact on carbon emissions the secure cold chain can have is therefore to ensure that every single dose that is manufactured reaches the patient securely and on time.
Are you familiar with the cold chain linguistics? Numerous abbreviations and internal phrases are used every day in the cold chain industry. To increase your knowledge of the industry, we will guide you through the terminology.